---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-021112"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-15T00:09:20.695089+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ernexa Therapeutics effects 1-for-25 reverse stock split, effective May 4, 2026

## Summary
- Reverse stock split at 1-for-25 ratio; trading on split-adjusted basis began at market open on May 4, 2026.
- Certificate of Amendment filed with Delaware Secretary of State on May 1, 2026.
- New CUSIP number for common stock post-split: 114082407.
- Common stock (ERNA) and warrants (ERNAW) trade on Nasdaq under split-adjusted terms.

## SEC filing metadata
- accession: 0001493152-26-021112
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000149315226021112/0001493152-26-021112-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000149315226021112/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-021112
- JSON: https://secwatch.observer/filing/0001493152-26-021112.json
- Plain text: https://secwatch.observer/filing/0001493152-26-021112.txt

## Source-grounded claims
- claim_id: 8b353b151ae030952a3af45a3111412469dbc3e3
  claim: Ernexa Therapeutics Inc.: Effected a 1-for-25 reverse stock split of common stock via certificate of amendment to the Restated Certificate of Incorporation (effective 2026-05-04).
  evidence_excerpt: On May 1, 2026, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation, as amended with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-25 (the “ Reverse Stock Split ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000149315226021112/0001493152-26-021112-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.